DK2177621T3 - Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation - Google Patents

Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation

Info

Publication number
DK2177621T3
DK2177621T3 DK10153338.8T DK10153338T DK2177621T3 DK 2177621 T3 DK2177621 T3 DK 2177621T3 DK 10153338 T DK10153338 T DK 10153338T DK 2177621 T3 DK2177621 T3 DK 2177621T3
Authority
DK
Denmark
Prior art keywords
methods
prevent
cell surface
surface receptors
reduce inflammation
Prior art date
Application number
DK10153338.8T
Other languages
English (en)
Inventor
Prem Sreenivasan
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38017086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2177621(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of DK2177621T3 publication Critical patent/DK2177621T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/18—Dental and oral disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
DK10153338.8T 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation DK2177621T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75775106P 2006-01-10 2006-01-10
EP07709990.1A EP1971865B1 (en) 2006-01-10 2007-01-08 Methods of modulating cell surface receptors to prevent or reduce inflammation

Publications (1)

Publication Number Publication Date
DK2177621T3 true DK2177621T3 (da) 2013-10-28

Family

ID=38017086

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07709990.1T DK1971865T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation
DK10153338.8T DK2177621T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07709990.1T DK1971865T3 (da) 2006-01-10 2007-01-08 Fremgangsmåder til modulering af celleoverfladereceptorer til at forebygge eller reducere inflammation

Country Status (18)

Country Link
US (1) US9157914B2 (da)
EP (2) EP1971865B1 (da)
JP (2) JP2009523029A (da)
CN (1) CN101371141A (da)
AR (1) AR058959A1 (da)
AU (1) AU2007204730B2 (da)
BR (1) BRPI0706505A2 (da)
CA (2) CA2635605C (da)
DK (2) DK1971865T3 (da)
ES (2) ES2431291T3 (da)
HK (2) HK1121235A1 (da)
MY (1) MY151118A (da)
PH (1) PH12014501163A1 (da)
PL (2) PL1971865T3 (da)
RU (1) RU2431845C2 (da)
TW (2) TW201415028A (da)
WO (1) WO2007082181A2 (da)
ZA (1) ZA200805730B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1971865B1 (en) * 2006-01-10 2013-04-17 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
TWI405565B (zh) 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗－骨質流失及抗－牙周附連喪失之功效
TWI481870B (zh) 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記
RU2526912C2 (ru) 2009-04-01 2014-08-27 Колгейт-Палмолив Компани Композиции карбонатных соединений, препятствующих образованию биопленки, для использования при уходе за полостью рта
RU2492857C2 (ru) 2009-04-01 2013-09-20 Колгейт-Палмолив Компани Соединения - производные ментола и их применение в качестве активных системных агентов и агентов для ротовой полости
WO2016179561A1 (en) 2015-05-06 2016-11-10 The Procter & Gamble Company Detoxification of microbial virulence factors in oral cavity
US9964472B2 (en) 2016-06-29 2018-05-08 The Procter & Gamble Company Methods for sampling gingival metabolites
EP4018196A1 (en) * 2020-04-02 2022-06-29 Colgate-Palmolive Company Compositions for and methods of neutralizing lipopolysaccharide toxicity and methods of identifying the same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) * 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) * 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) * 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) * 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) * 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
US5840302A (en) * 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) * 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
ES2162304T3 (es) 1996-06-12 2001-12-16 Cognis Deutschland Gmbh Preparaciones cosmeticas y/o farmaceuticas.
DE69831522T2 (de) 1997-03-03 2006-06-14 Amersham Biosciences Uk Ltd In-situ Zellextraktion und Assay-Verfahren
JP2000128900A (ja) 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6696261B2 (en) * 1999-12-03 2004-02-24 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
WO2002066978A2 (en) 2000-12-29 2002-08-29 Reddy Us Therapeutics, Inc. Detection of compounds that modulate inflammatory responses
SG152907A1 (en) 2001-07-09 2009-06-29 Combinatorx Inc Combinations for the treatment of inflammatory disorders
US6893828B2 (en) 2001-09-06 2005-05-17 Decode Genetics Ehf. Methods for producing ex vivo models for inflammatory disease and uses thereof
WO2003088917A2 (en) 2002-04-19 2003-10-30 Vertex Pharmaceuticals Incorporated Regulation of tnf-alpha
US7005225B2 (en) * 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
MXPA05008649A (es) * 2003-02-14 2005-11-23 Combinatorx Inc Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios.
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
JP2007514648A (ja) * 2003-10-24 2007-06-07 エーザイ株式会社 Ｔｏｌｌ−ｌｉｋｅｒｅｃｅｐｔｏｒ２に関連する疾患及び状態を治療するための化合物及び方法
ES2320139T3 (es) * 2003-12-03 2009-05-19 Whitehead Institute For Biomedical Research Uso de t-cadherina soluble para el tratamiento de trastornos metabolicos.
JP2005304365A (ja) 2004-04-20 2005-11-04 Japan Science & Technology Agency Ｔｌｒリガンド及びｉｌ−１応答障害性モデル動物
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20060141421A1 (en) * 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) * 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
EP1971865B1 (en) * 2006-01-10 2013-04-17 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
EP1971865B1 (en) 2013-04-17
CA2635605C (en) 2014-07-08
ES2421595T3 (es) 2013-09-04
PL2177621T3 (pl) 2014-03-31
AR058959A1 (es) 2008-03-05
US9157914B2 (en) 2015-10-13
TW201415028A (zh) 2014-04-16
BRPI0706505A2 (pt) 2011-03-29
HK1121235A1 (en) 2009-04-17
DK1971865T3 (da) 2013-07-08
ES2431291T3 (es) 2013-11-25
EP2177621B1 (en) 2013-10-09
WO2007082181A3 (en) 2007-09-27
ZA200805730B (en) 2014-12-23
CA2635605A1 (en) 2007-07-19
EP2177621A3 (en) 2010-09-08
AU2007204730A1 (en) 2007-07-19
RU2008132839A (ru) 2010-02-20
AU2007204730B2 (en) 2011-11-17
JP2015051000A (ja) 2015-03-19
TW200801514A (en) 2008-01-01
PH12014501163A1 (en) 2015-05-18
WO2007082181A2 (en) 2007-07-19
HK1141838A1 (en) 2010-11-19
CN101371141A (zh) 2009-02-18
CA2849559A1 (en) 2007-07-19
RU2431845C2 (ru) 2011-10-20
PL1971865T3 (pl) 2014-02-28
MY151118A (en) 2014-04-15
US20070160544A1 (en) 2007-07-12
EP1971865A2 (en) 2008-09-24
JP2009523029A (ja) 2009-06-18
EP2177621A2 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
DE102008055028A8 (de) Solarzelle
DK2155838T3 (da) Fremgangsmåde til fremstilling af forgrenede carbonhydrider
DK2356298T3 (da) Kunstigt surfanlæg
DK2177621T3 (da) Fremgangsmåder til modulering af celleoverfladereceptorer til forebyggelse eller reduktion af inflammation
IT1392792B1 (it) Impianto fotovoltaico galleggiante
DK2277222T3 (da) Brændselscellesystem
DK1979314T3 (da) Indolsulfonamidmodulatorer af progesteronreceptorer
DK2140499T3 (da) Solmodul til skråtag
FR2917714B1 (fr) Turboreacteur pour aeronef
DE602008000048D1 (de) Brennstoffzelle
DE112007002407B8 (de) Brennstoffzelle
DE112007001371B8 (de) Brennstoffzelle
DE112009002161A5 (de) Photovoltaikanlage
DE602008006595D1 (de) Überlaufbauwerk
DE112009002696T8 (de) Brennstoffzellensystem
DE102008055036A8 (de) Solarzelle
DE602008006153D1 (de) Einkristall-turbinenschaufel
DE602008002852D1 (de) Brennstoffzellsystem
FR2926789B1 (fr) Nacelle pour turboreacteur
DE602006009405D1 (de) Mehrzellenpumpe
DK2183042T3 (da) Væskeseparator
DE602007007302D1 (de) Brennstoffzelle
DE112009002448T8 (de) Brennstoffzelle
BRPI0917918A2 (pt) estrutura de concreto flutuante
ATE490113T1 (de) Kraftstofftank